Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mild Cognitive Impairment, Use of qEEG as a Prognostic Marker

NCT03659643 is registered in ClinicalTrials.gov with Jon Snaedal as lead sponsor.

NCT NCT03659643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03659643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mild Cognitive Impairment, Use of qEEG as a Prognostic Marker
Lead sponsor
Jon Snaedal
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2018
Completion date
October 1, 2020
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment